EMT significantly alters the dynamic environment of TME, drawing stromal and immune cells from different tissues to the TME through cytokines (such as TGF-β) and chemokines (such as CXCL2, CCL22, MMP, IL-6, and IL-8) released by breast cancer cells. This evidence concerns the gene IL6 and breast carcinoma.